Microbe

David Mead on "Next Generation DNA Polymerases & Reverse Transcriptases"

submitted by: JGI
David Mead of Lucigen Corporation discusses polymerase development, Yellowstone and sequencing at the "Sequencing, Finishing, Analysis in the Future" meeting in Santa Fe, NM on May 28, 2009.

Tim Harkins on "The 8 day challenge for 8 genomes"

submitted by: JGI
Tim Harkins of Roche Diagnostics talks about what he calls "The Edwards & Eisen Challenge" at the "Sequencing, Finishing, Analysis in the Future" meeting in Santa Fe, NM on May 27, 2009.

Jessica Hostetler on "Human Microbiome Finishing"

submitted by: JGI
Jessica Hostetler from The J. Craig Venter Institute speaks at the "Sequencing, Finishing, Analysis in the Future" meeting in Santa Fe, NM on May 27, 2009.

Tuberculosis: A Persistent Threat to Global Health - Part 4: Targeting M. tuberculosis Carbon Metabolism In Vivo (26:12)

submitted by: video_collector
All pathogens must acquire and assimilate nutrients from their hosts in order to grow and multiply -- our tissues are literally their food -- yet surprisingly little is known about this fundamental aspect of the pathogenic lifestyle. Accumulating evidence suggests that M. tuberculosis might utilize fatty acids as its principal carbon and energy source during infection. The fourth part of this lecture describes work in our laboratory that is focused on identifying the metabolic pathways that...

Tuberculosis: A Persistent Threat to Global Health - Part 3: Phenotypic Heterogeneity and Antibiotic Tolerance (27:15)

submitted by: video_collector
The principal obstacle to successful treatment of tuberculosis is the lengthy duration of current regimens, which require administration of multiple drugs for 6-9 months. The requirement for prolonged therapy is attributed to sub-populations of bacillary "persisters" that are refractory to antimicrobials. The persisters are not drug-resistant in the conventional (heritable) sense and it is a mystery why they are spared whilst their genetically identical siblings are killed. The third part of...

Tuberculosis: A Persistent Threat to Global Health - Part 2: Tools for Tuberculosis Control: Not Just a Problem of Implementation (28:18)

submitted by: video_collector
Tuberculosis remains one of the most important causes of human disease and death despite the introduction of vaccination in 1921 and chemotherapy in 1952. Although these interventions are inexpensive and widely available their impact is limited. The effectiveness of vaccination is unclear; in clinical trials, the protection conferred by vaccination has been variable and generally poor. Although chemotherapy can be highly effective, multiple drugs must be administered for 6-9 months to provide...

Tuberculosis: A Persistent Threat to Global Health - Part 1: Tuberculosis: The Once and Future Plague (27:33)

submitted by: video_collector
Human population growth and urbanization have accelerated dramatically in recent centuries, providing unprecedented opportunities for microbes that use our bodies as vehicles for their own propagation and transmission. These conditions have led to the emergence of virulent new pathogens and the increased prevalence of "classic" scourges, such as Mycobacterium tuberculosis. This tenacious microbe is transmitted via infectious aerosols produced by individuals with pulmonary tuberculosis....

Microbe Lab (MWV13)

submitted by: MicrobeWorld
MicrobeWorld visits the Marian Koshland Science Museum for “Microbe Lab,” a free day of activities for the general public. In this episode we interview Erika Shugart, deputy director of the Koshland Museum, about “Microbe Lab” and the Crack Koshie’s Curious Case: A Disease Detective Mission activity. Next, we talk with Nagla Fetouh, Education Program Manager for the Koshland Museum, who led a disease exchange activity that teaches people about ways to control the spread of...